BVAITRandomized, double-blind, placebo-controlled, 2.5-year non-invasive arterial imaging primary prevention clinical trial to determine if B-vitamin supplementation reduces the progression of atherosclerosis (carotid intima-media thickness and coronary and abdominal calcification) in healthy men and women 40 years and older

Funding Source

This study was supported by the National Institute on Aging, NationalInstitutes of Health. Leiner Health Products provided the B-vitamin supplements and placebo

Registered at under NCT00114400